Cam Gallagher - Dec 6, 2021 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Role
Director
Signature
By: /s/ Melissa B. Epperly, Attorney-in-Fact for Cam S. Gallagher
Stock symbol
ZNTL
Transactions as of
Dec 6, 2021
Transactions value $
-$713,300
Form type
4
Date filed
12/7/2021, 07:35 PM
Previous filing
Nov 16, 2021
Next filing
Dec 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZNTL Common Stock Sale -$713K -10K -2.29% $71.33 427K Dec 6, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021.